# Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer

> **NCT00017563** · PHASE2 · COMPLETED · sponsor: **OHSU Knight Cancer Institute** · enrollment: 57 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** docetaxel
- **DRUG:** mitoxantrone hydrochloride
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00017563
- **Lead sponsor:** OHSU Knight Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2010-05
- **Final completion:** —
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2017-04-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017563, "Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00017563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*